The PAMCET Learning Team is the institutional curriculum and content group behind course publishing on this platform. PAMCET (Professional and Academic Management Centre for Education and Training) is operated by Digitpen Hub Ltd, a company registered in Lagos, Nigeria. Courses credited to the PAMCET Learning Team are structured, organized, and published centrally by the platform rather than authored by a single named individual instructor — each course's syllabus, learning outcomes, and content are reviewed before publication under this institutional account. For questions about a specific course or to report a content issue, please use the platform's Help & Support or Contact Us pages.
MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level)
Oncological principles, tumor staging (TNM), systemic antineoplastic regimens, acute/chronic leukemias, lymphomas, multiple myeloma, and end-of-life palliative care.
Course Overview
Oncological principles, tumor staging (TNM), systemic antineoplastic regimens, acute/chronic leukemias, lymphomas, multiple myeloma, and end-of-life palliative care. Curriculum Structure & Core Modules: • 1. Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM...
What You'll Learn
- Classify solid tumors by TNM staging and formulate multidisciplinary tumor board treatment recommendations.
- Recognize and immediately manage oncological emergencies: neutropenic fever, SVC syndrome, and cord compression.
- Diagnose and manage acute lymphoblastic/myeloblastic leukemias, chronic leukemias, and Hodgkin/Non-Hodgkin lymphomas.
- Evaluate clinical presentation and laboratory staging (CRAB criteria) in multiple myeloma.
- Apply the WHO pain ladder and manage end-of-life symptoms (dyspnea, nausea, delirium) in palliative care patients.
Requirements
- MED 401 credit
- PTH 401 credit
Degree Programme Curriculum Context
This course is a curriculum unit of the Bachelor of Medicine, Bachelor of Surgery (MBBS) degree framework in Nigeria.
Earn Your Certificate
Showcase your skills with a certificate! Complete the course, submit your project, and earn your certificate. Here's a sample of what you'll receive to show off your accomplishments.

Course Curriculum
Browse complete theoretical foundations, worked calculations, laboratory protocols, and board assessment questions under each topic.
Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 1 • Lecture 1 Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Medicine & S...
Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 1 • Lecture 2 Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professional MBBS...
Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Principles of Clinical Oncology: Carcinogenesis, Biomarkers, TNM Staging & Multidisciplinary Care.
Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 2 • Lecture 1 Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Medic...
Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 2 • Lecture 2 Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professiona...
Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Antineoplastic Therapies: Cytotoxics, Targeted Tyrosine Kinase Inhibitors & Immune Checkpoint Inhibitors.
Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 3 • Lecture 1 Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal...
Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 3 • Lecture 2 Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Profe...
Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Oncological Emergencies: Febrile Neutropenia, Superior Vena Cava Obstruction, Cord Compression & Hypercalcemia.
Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 4 • Lecture 1 Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Medicine & Systemi...
Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 4 • Lecture 2 Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professional MBBS Exam /...
Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Tumor Lysis Syndrome: Risk Stratification, Hydration, Rasburicase & Allopurinol Prophylaxis.
Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 5 • Lecture 1 Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal M...
Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 5 • Lecture 2 Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Profess...
Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Hematologic Malignancies I: Acute Myeloid & Lymphoblastic Leukemias, FAB/WHO Classifications & Remission.
Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 6 • Lecture 1 Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal...
Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 6 • Lecture 2 Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Profes...
Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Hematologic Malignancies II: Chronic Myeloid Leukemia (BCR-ABL, Imatinib), CLL & Hodgkin/Non-Hodgkin Lymphoma.
Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 7 • Lecture 1 Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Me...
Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 7 • Lecture 2 Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professi...
Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Multiple Myeloma & Plasma Cell Disorders: CRAB Criteria, Serum Protein Electrophoresis & Autologous SCT.
Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Structural Principles & Pathophysiological Derangements
MED 502 • 500L • Internal Medicine • Chapter 8 • Lecture 1 Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Structural Principles, Functional Architecture & Pathophysiological Derangements Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • Internal Me...
Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Clinical Semiology, Differential Diagnosis & Evidence-Based Management
MED 502 • 500L • Internal Medicine • Chapter 8 • Lecture 2 Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Clinical Semiology, Differential Diagnosis & Evidence-Based Bedside Management Curriculum Reference: MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level) • MDCN Professi...
Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement: Formative Clinical Case Assessment
Authentic clinical vignette self-assessment evaluating semiology, diagnostic decision-making, and therapeutics for Palliative & End-of-Life Care: Symptom Control, Opioid Titration, Advance Care Directives & Bereavement.
Academic Ecosystem & Connected Pathways
Deepen your studies across connected learning pathways in the PAMCET academic network:
Instructor
PAMCET Learning Team
Institutional Course Curation · PAMCET
Qualifications:
PAMCET Learning Team — Institutional Course Curation, Digitpen Hub LtdMy Skills:
- Curriculum Curation
- Course Content Review
- Learning Outcome Design
- Course Publishing & Quality Assurance
- Platform Content Operations
Reviews
Course Includes
Download Syllabus & Study Guide
Receive the full lecture syllabus, reading list, and milestone schedule for MED 502: Clinical Oncology, Hematologic Malignancies & Palliative Care (500 Level).
By submitting, you agree to receive educational updates. You can unsubscribe anytime. Read our Privacy Policy.

